InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,597.12
(
-0.20%
)
US TECH 100
19,241.60
(
0.16%
)
Dow Jones
40,834.97
(
-0.15%
)
Brent Oil
76.81
(
0.07%
)
Bitcoin
59,468.17
(
0.78%
)
Post# of 252938
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

turtlepower

Send PM Follow Ignore
Followers 1
Posts 1114
Boards Moderated 0
Alias Born 04/07/2009

turtlepower

Re: DewDiligence post# 95897

Wednesday, 05/26/2010 7:21:16 AM

Wednesday, May 26, 2010 7:21:16 AM

Post# of 252938
I had assumed MRK would be able to see the total number of anemia cases from the other ongoing trials in addition to the open label one. Assuming they have a theoretical worst case value for the placebo arm (an absolute minimum which could be zero) they should be able to approximate the number of cases on the treatment arm and figure out by now whether this is a serious issue. The open label study may not have recruited enough patients by now to make any assumption. Is this unrealistic?
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up